ENvue Medical Inc
FEED
7 hedge funds and large institutions have $327K invested in ENvue Medical Inc in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
166% more capital invested
Capital invested by funds: $123K → $327K (+$204K)
0.11% more ownership
Funds ownership: 0.05% → 0.16% (+0.11%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
13% less funds holding
Funds holding: 8 → 7 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$247K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$10.5K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$758 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4.07K |
| 2 |
Renaissance Technologies
New York
|
-$2.38K |
| 3 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$122 |
| 4 |
BlackRock
New York
|
-$85 |
FEED Hedge Fund Activity: Q1 2024 in Review
7 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q1 2024, worth a combined $327K — up 166% from $123K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of FEED and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $247K. The largest seller was UBS Group, exiting entirely with an estimated $4.07K sold.
- 7 institutional investors held ENvue Medical Inc (FEED) as of Q1 2024, down from 8 in Q4 2023.
- Funds reported $327K of ENvue Medical Inc stock for Q1 2024, up 166% quarter-over-quarter.
- 2 funds opened new ENvue Medical Inc positions in Q1 2024 and 3 closed out, a net change of -1 holder.
- The largest ENvue Medical Inc buyer in Q1 2024 was Armistice Capital, an estimated $247K added.
- The largest ENvue Medical Inc seller in Q1 2024 was UBS Group, an estimated $4.07K sold.
Based on aggregated 13F filings for Q1 2024.